Exploring ADC pharmacokinetics using QSP [APAC Webinar]
The Pharmacokinetics (PK) of ADC therapeutics typically show a discrepancy between the PK of total antibody and that of conjugated antibody, carrying one or more payload molecules. This discrepancy is often attributed to deconjugation, however recent evidence suggests that the underlying mechanisms may be more complex. In this webinar, we will present how quantitative systems … <a href="https://jp.certara.com/webinar/exploring-adc-pharmacokinetics-using-qsp-apac-webinar/">Continued</a>